Can analysts adopt a bullish outlook for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)?

August 11, 2017 - By Vivian Park

 Can analysts adopt a bullish outlook for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)?

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Ratings Coverage

Among 2 analysts covering Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Tonix Pharmaceuticals Holding Corp. had 4 analyst reports since August 20, 2015 according to SRatingsIntel. The stock has “Buy” rating by Cantor Fitzgerald on Wednesday, November 4. Aegis Capital initiated it with “Buy” rating and $1000 target in Monday, June 26 report. Oppenheimer maintained Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) on Thursday, August 20 with “Outperform” rating. The firm earned “Buy” rating on Thursday, June 2 by Cantor Fitzgerald. Below is a list of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) latest ratings and price target changes.

26/06/2017 Broker: Aegis Capital Rating: Buy New Target: $10.0000 Initiate

The stock decreased 4.26% or $0.14 on August 11, reaching $3.15. About 118,468 shares traded or 35.90% up from the average. Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) has declined 82.55% since August 11, 2016 and is downtrending. It has underperformed by 99.25% the S&P500.

More notable recent Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) news were published by: Globenewswire.com which released: “Tonix Pharmaceuticals Presented Retrospective Analyses of Treatment Response …” on May 30, 2017, also Globenewswire.com with their article: “Tonix Pharmaceuticals to Present PTSD Clinical Data at the Society of …” published on May 11, 2017, Globenewswire.com published: “Tonix Pharmaceuticals to Present Breakthrough Therapy Designated-PTSD Program …” on March 07, 2017. More interesting news about Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) were released by: Globenewswire.com and their article: “Tonix Pharmaceuticals Announces 1-for-10 Reverse Stock Split” published on March 16, 2017 as well as Globenewswire.com‘s news article titled: “Tonix Pharmaceuticals to Present Additional Clinical Results of Military …” with publication date: May 24, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.